Stocktoria
Taysha Gene Therapies, Inc. TSHA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-24
Taysha Gene Therapies, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 11,742,449 | $26.3M |
| D. E. Shaw & Co., Inc. | 4,427,301 | $19.8M |
| MILLENNIUM MANAGEMENT LLC | 3,281,820 | $14.7M |
| TWO SIGMA INVESTMENTS, LP | 742,081 | $3.3M |
| CITADEL ADVISORS LLC | 506,835 | $2.3M |
| Point72 Asset Management, L.P. | 461,856 | $2.1M |
| RENAISSANCE TECHNOLOGIES LLC | 413,203 | $1.8M |
| AQR CAPITAL MANAGEMENT LLC | 177,309 | $792,571 |
Source: SEC EDGAR filings · CIK 0001806310 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.